These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 25479747)

  • 21. Colon cancer stem cells: Potential target for the treatment of colorectal cancer.
    Gupta R; Bhatt LK; Johnston TP; Prabhavalkar KS
    Cancer Biol Ther; 2019; 20(8):1068-1082. PubMed ID: 31050577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells.
    van der Flier LG; Haegebarth A; Stange DE; van de Wetering M; Clevers H
    Gastroenterology; 2009 Jul; 137(1):15-7. PubMed ID: 19450592
    [No Abstract]   [Full Text] [Related]  

  • 23. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential.
    Gao W; Chen L; Ma Z; Du Z; Zhao Z; Hu Z; Li Q
    Gastroenterology; 2013 Sep; 145(3):636-46.e5. PubMed ID: 23747337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.
    Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T
    Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pluripotent human stem cell lines: what we can learn about cancer initiation.
    Werbowetski-Ogilvie TE; Bhatia M
    Trends Mol Med; 2008 Aug; 14(8):323-32. PubMed ID: 18635398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy.
    Takao S; Ding Q; Matsubara S
    J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):614-20. PubMed ID: 22878838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
    Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
    In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.
    Kemper K; Prasetyanti PR; De Lau W; Rodermond H; Clevers H; Medema JP
    Stem Cells; 2012 Nov; 30(11):2378-86. PubMed ID: 22969042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA interference in the treatment of colon cancer.
    Prados J; Melguizo C; Roldan H; Alvarez PJ; Ortiz R; Arias JL; Aranega A
    BioDrugs; 2013 Aug; 27(4):317-27. PubMed ID: 23553339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
    Vogler T; Kriegl L; Horst D; Engel J; Sagebiel S; Schäffauer AJ; Kirchner T; Jung A
    Exp Mol Pathol; 2012 Feb; 92(1):111-7. PubMed ID: 22101256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of HIWI and HILI Expression with Cancer Stem Cell Markers in Colorectal Cancer.
    Litwin M; Dubis J; Arczyńska K; Piotrowska A; Frydlewicz A; Karczewski M; Dzięgiel P; Witkiewicz W
    Anticancer Res; 2015 Jun; 35(6):3317-24. PubMed ID: 26026091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer.
    Pang R; Law WL; Chu AC; Poon JT; Lam CS; Chow AK; Ng L; Cheung LW; Lan XR; Lan HY; Tan VP; Yau TC; Poon RT; Wong BC
    Cell Stem Cell; 2010 Jun; 6(6):603-15. PubMed ID: 20569697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pluripotency network in colorectal cancer pathogenesis and prognosis: an update.
    Voutsadakis IA
    Biomark Med; 2018 Jun; 12(6):653-665. PubMed ID: 29944017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment.
    Yang HZ; Ma Y; Zhou Y; Xu LM; Chen XJ; Ding WB; Zou HB
    Cancer Lett; 2015 May; 361(1):128-36. PubMed ID: 25749420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EMT in breast cancer stem cell generation.
    Ansieau S
    Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26(+) cancer stem cells in colorectal carcinoma.
    Chow AK; Cheng NS; Lam CS; Ng L; Wong SK; Wan TM; Man JH; Cheung AH; Yau TC; Poon JT; Law WL; Pang RW
    Mol Cancer; 2015 Apr; 14():80. PubMed ID: 25884645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer.
    Fumagalli A; Oost KC; Kester L; Morgner J; Bornes L; Bruens L; Spaargaren L; Azkanaz M; Schelfhorst T; Beerling E; Heinz MC; Postrach D; Seinstra D; Sieuwerts AM; Martens JWM; van der Elst S; van Baalen M; Bhowmick D; Vrisekoop N; Ellenbroek SIJ; Suijkerbuijk SJE; Snippert HJ; van Rheenen J
    Cell Stem Cell; 2020 Apr; 26(4):569-578.e7. PubMed ID: 32169167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enrichment of colorectal cancer stem cells through epithelial-mesenchymal transition via CDH1 knockdown.
    Ye J; Wu D; Shen J; Wu P; Ni C; Chen J; Zhao J; Zhang T; Wang X; Huang J
    Mol Med Rep; 2012 Sep; 6(3):507-12. PubMed ID: 22684815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.
    He S; Zhou H; Zhu X; Hu S; Fei M; Wan D; Gu W; Yang X; Shi D; Zhou J; Zhou J; Zhu Z; Wang L; Li D; Zhang Y
    Biomed Pharmacother; 2014 Jun; 68(5):507-13. PubMed ID: 24751002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.
    Todaro M; Gaggianesi M; Catalano V; Benfante A; Iovino F; Biffoni M; Apuzzo T; Sperduti I; Volpe S; Cocorullo G; Gulotta G; Dieli F; De Maria R; Stassi G
    Cell Stem Cell; 2014 Mar; 14(3):342-56. PubMed ID: 24607406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.